(October 28, 2022) The Reagan-Udall Foundation for the FDA is pleased to announce the launch of its Regulatory Science, Innovation, and Health Equity Fellowship Program. Increasing diversity in regulatory science serves to bring varied perspectives into the field and generate more meaningful results. By working directly on the priorities of the FDA and the Foundation, the fellowship will offer a unique opportunity for individuals to begin a career in regulatory science, while advancing health equity within the regulatory science workforce.

(October 27, 2022) The Reagan-Udall Foundation for the FDA will present 2022 Innovations in Regulatory Science Awards to Robert Temple, MD; Medidata; and George Vradenburg on December 6 at the Mayflower Hotel in Washington, DC. The awards recognize outstanding contributions to regulatory science and public health in three categories: Leadership, Innovation, and Advocacy/Policy.  

TOBACCO PROGRAM REVIEW PANEL ENTERS DAY 3 OF LISTENING SESSIONS — The five-person expert panel tasked with evaluating the FDA’s tobacco regulatory program will embark on its final listening sessions from industry, legal and public health experts today.
Read more

Members of the Food and Drug Administration’s food program evaluation panel have a big job as they develop recommendations for FDA guidance.

At a public meeting last month and in the hundreds of comments received through the online portal members of a Reagan-Udall Foundation panel tasked with examining the agency’s “structure/leadership, authority, resources and culture” were told that problems in the food program are deep-rooted and complex, leading to a lack of accountability and delayed decision-making.

(October 13, 2022) The Reagan-Udall Foundation today announced a series of upcoming virtual meetings and opened a Stakeholder Portal to solicit input for the Independent Expert Panel’s evaluation of certain portions of FDA’s tobacco program.